Loss Per Share

9 Months Ended

Sep. 30, 2020

The following table sets forth the computation of unaudited basic and diluted loss per share for the three and nine months ended September 30, 2020 and 2019 (in thousands, except share and per share data):


	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
	(Unaudited)				(Unaudited)

Numerator (both basic and diluted):
Loss from continuing operations	$	(29,153)	$	(24,777)	$	(205,308)	$	(58,879)
Loss from discontinued operations, net of tax	(2,926)		(14,100)		(16,250)		(35,251)
Net loss available to common stockholders	$	(32,079)	$	(38,877)	$	(221,558)	$	(94,130)
Denominator:
Denominator for basic and diluted earnings per share	24,927,369		25,606,264		24,932,900		26,551,592

Basic and diluted loss per common share from continuing operations:	$	(1.17)	$	(0.97)	$	(8.23)	$	(2.22)
Basic and diluted loss per common share from discontinued operations:	$	(0.12)	$	(0.55)	$	(0.65)	$	(1.33)
Basic and diluted loss per common share available to stockholders:	$	(1.29)	$	(1.52)	$	(8.88)	$	(3.55)

The Company has issued potentially dilutive instruments such as the Series A Preferred Stock, unvested restricted stock and common stock options. However, the Company did not include these instruments in its calculation of diluted per share information, because to include them would be anti-dilutive due to the net loss incurred during the periods presented.

The following table sets forth weighted average shares outstanding of potentially dilutive instruments for the three and nine months ended September 30, 2020 and 2019:


	Three Months Ended September 30,		Nine Months Ended September 30,
	2020	2019	2020	2019

	(Unaudited)		(Unaudited)
Stock options	194,264	511,558	194,264	511,558
Series A Preferred stock	118,805,000	—	88,886,953	—
Warrants	2,066,576	2,066,576	2,066,576	2,066,576
Weighted average unvested restricted stock	187,537	631,742	289,758	326,054
Total	121,253,377	3,209,876	91,437,551	2,904,188